Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Research and development spending
3Y CAGR
-0.1%/yr
Annual compound
5Y CAGR
-2.7%/yr
Consistent
Percentile
P33
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $158.68M | -7.5% |
| 2024 | $171.60M | -6.2% |
| 2023 | $182.94M | +14.9% |
| 2022 | $159.19M | +14.8% |
| 2021 | $138.69M | -23.9% |
| 2020 | $182.24M | +186.6% |
| 2019 | $63.59M | - |